Compositions for increasing body weight, use and methods
WO2006085224A2
Modulation of cellular hypoxia responses through notch signalling
WO2006031194A1
A method of screening for a compound having antitumor activity by using eukaryotic cell overexpressing at least one myc gene and/or having a deficient mat regulator activity
WO2006008650A2
Dna methylation in the assessment of leukemia
WO2006004552A1
Transgenic non-human animal for use in research models for studying parkinson's disease
GB0422908D0
Methods and means for inhibiting lipolysis
WO2005023851A1
Plasminogen/plasmin binding polypeptides and nucleic acids therefore
EP1673468A2
Methods for identifying compounds for inhibiting fever
AU2003271297A1
PGE synthase and methods and means for modulating its activity
GB0326416D0
Methods and means relating to hepatitis B infection
WO2004037282A1
The use of cytochrome p450 enzyme cyp2wi as a drug traget for cancer therapy
US2004241798A1
ADH7 nucleotides
WO03090113A1
Methods and arrangements for biological imaging
WO03065036A1
Method of identifying insulin secretion stimulating compounds, and the use of such compounds in treating insulin-secretion related disorders
SE0203105D0
Reactivation of wild type P53 in human tumour cells by a low molecular weight compound
GB0222162D0
Methods and materials relating to neurogenesis
AU2002338561A1
Lipid producing cells and uses thereof
CA2444994A1
Methods for high throughput genome analysis using restriction site tagged microarrays
